brand-logo

Accelagen Staff Announcement: Suzanne Leong

Accelagen Staff Announcement: Suzanne Leong

We are excited to formally welcome another highly experienced team member to Accelagen’s fast-growing Australian team, Suzanne Leong.

Joining the Accelagen team is Suzanne Leong, the company’s new Senior Clinical Data Manager, bringing with her over 20 years’ experience across Clinical Research Organisations (CROs), Pharmaceutical and Public Health industries.

With a Bachelor of Science in Microbiology and Immunology, as well as a Master of Technology Management, both from University of New South Wales (UNSW), Suzanne has a long track record of developing clinical trial databases and maintaining high quality clinical data.

She is both passionate about and proficient at bringing a high level of attention to detail to helping solve the kind of real-world, complex and nuanced research questions that we pride ourselves on at Accelagen.

Her role will give her the opportunity to use the wide range of knowledge and expertise she has gathered over two decades across various therapeutic areas, including Oncology, Infectious Diseases, Dermatology, Cardiology, and Endocrinology, and she will help us provide world-class expertise in clinical research services and data management.

A warm Accelagen welcome to Suzanne.

You might also like...​

Welcoming our new Business Planning and Analysis Manager

Welcoming our new Business Planning and Analysis Manager   Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis. […]

Read More
Hands operating syringe
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results

Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian market Engaged by world-renowned European clients and collaborators, Memo Therapeutics AG (“MTx”) based in Switzerland, and Vakzine Projekt Management GmbH (VPM) based […]

Read More
Amritha
Accelagen Staff Announcement: Amritha Vangur

Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again! Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate. Amritha first worked at Accelagen in 2019. The company was in its infancy at the time, with a small, tight-knit team. Shortly after joining, Amritha travelled overseas and […]

Read More